Sectors

WST
West Pharmaceutical Services, Inc.
341.46
1 x 342.13
1 x 342.88
bid
ask
+
5.07
1.51%
01:37 PM
timesize
Ytd 24.10%
1y 53.34%
338.73
day range
345.99
210.08
52 week range
341.83
Open 335.72 Prev Close 336.39 Low 338.73 High 345.99 Mkt Cap 24.15B
Vol 371.46K Avg Vol 839.43K EPS 7.47 P/E 45.77 Forward P/E 34.50
Beta 1.18 Short Ratio 2.90 Inst. Own 103.94% Dividend 0.88 Div Yield 0.27
Ex Div Date 04-29 Earning 07-23 50-d Avg 307.98 200-d Avg 272.50 1yr Est 358.79
Earning
Date For Estimate Reported Surprise surprise %
2026-04-23 2026-03 1.68 2.13 0.45 26.79%
2026-02-12 2025-12 1.83 2.04 0.21 11.48%
2025-10-23 2025-09 1.67 1.96 0.29 17.37%
2025-07-24 2025-06 1.51 1.84 0.33 21.85%
2025-04-24 2025-03 1.22 1.45 0.23 18.85%
2025-02-13 2024-12 1.75 1.82 0.07 4.00%
Upgrade / Downgrade
Date Firm Action From To
2026-06-09 Barclays Upgrade Equal-Weight Overweight
2026-06-02 Stephens & Co. Upgrade Overweight Overweight
2026-05-29 Morgan Stanley Upgrade Equal-Weight Equal-Weight
2026-04-27 Barclays Upgrade Equal-Weight Equal-Weight
2026-04-14 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-13 Barclays Upgrade Equal-Weight Equal-Weight
Profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Insider Holder
Date Name Relation Quantity Description
2025-02-17 BIRKETT BERNARD JOHN Chief Financial Officer 7.52K Conversion of Exercise of derivative security
2026-05-03 BUTHMAN MARK A Director 44.31K Stock Award(Grant)
2026-04-26 FAVORITE ANNETTE F Officer 21.80K Sale
2026-05-03 FEEHERY WILLIAM F. Director 32.52K Stock Award(Grant)
2026-02-17 GREEN ERIC MARK Chief Executive Officer 175.42K Conversion of Exercise of derivative security
2025-05-05 HOFMANN THOMAS W Director 44.64K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 6.84M 2.30B 9.68%
2026-03-30 Vanguard Capital Management LLC 4.68M 1.58B 6.63%
2026-03-30 Vanguard Portfolio Management LLC 4.09M 1.38B 5.79%
2026-03-30 State Street Corporation 3.29M 1.11B 4.66%
2026-03-30 Artisan Partners Limited Partnership 2.66M 894.06M 3.76%
2026-03-30 Bank Of New York Mellon Corporation 2.47M 829.47M 3.49%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 2.29M 770.99M 3.24%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 1.83M 615.28M 2.59%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.56M 523.21M 2.20%
2026-03-30 T. Rowe Price Mid-Cap Growth Fund, Inc. 1.06M 356.80M 1.50%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Growth Index Fund 981.39K 330.12M 1.39%
2026-04-29 iShares Trust-iShares Core S&P 500 ETF 930.55K 313.02M 1.32%
Dividend
Dividend Date
0.22 2026-04-29
0.22 2026-01-28
0.22 2025-11-12
0.21 2025-07-30
0.21 2025-04-30
0.21 2025-02-07
Split
Split Date
2 : 1 2013-09-27
2 : 1 2004-09-30
2 : 1 2004-09-29
2 : 1 1987-06-02
2 : 1 1982-05-06